|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jun 13, 2012||referred to health|
delivered to assembly
ordered to third reading cal.1251
committee discharged and committed to rules
|May 15, 2012||reported and committed to finance|
|May 02, 2012||referred to health|
senate Bill S7326
Directs the commissioner of health to establish an opioid treatment and hospital diversion demonstration program
Archive: Last Bill Status - Passed Senate
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
view actions (7)
Jun 13, 2012 - floor VoteS7326600floor60Aye0Nay0Absent2Excused0Abstained
show floor vote details
Floor Vote: Jun 13, 2012aye (60)
Jun 13, 2012 - Rules committee VoteS7326240committee24Aye0Nay0Aye with Reservations0Absent1Excused0Abstained
May 15, 2012 - Health committee VoteS7326130committee13Aye0Nay4Aye with Reservations0Absent0Excused0Abstained
- show floor vote details
S7326 - Bill Details
- See Assembly Version of this Bill:
- Current Committee:
- Law Section:
- Public Health Law
- Laws Affected:
- Add §3309-b, Pub Health L
S7326 - Bill Texts
Directs the commissioner of health to establish an opioid addiction treatment and hospital diversion demonstration program.
view sponsor memo
TITLE OF BILL:
to amend the public health law, in relation to establishing an opioid
addiction treatment and hospital diversion demonstration program
Directs the commissioner of health to establish an opioid treatment
and hospital diversion demonstration program
SUMMARY OF PROVISIONS:
Section 1 adds a new Public Health Law §331 0 to establish the Opioid
Treatment and Hospital Diversion Demonstration Program. Under the
program the commissioner is authorized to established up to six
demonstrations with, at minimum, one located in each of the following
locations; Western New York, Central New York, State Island,
Brooklyn, and Long Island.
Additionally, this section requires the commissioner to report on the
effectiveness of the demonstration program and recommendations
regarding the expansion of the program.
Section 2 provides the act take effect immediately.
The Centers for Disease Control and Prevention (CDC) recently reported
that in one year, 27,000 Americans died of unintentional drug
overdoses - that is one death every 19 minutes. Further, the CDC
reported that for every unintentional overdose death related to
opioids, nine persons are admitted for substance abuse treatment and
35 individuals visit emergency departments.
According to a study in the journal Psychiatric Services, substance
abuse disorders are costing states millions of dollars in Medicaid
expenses. This study found that in six states, the Medicaid programs
spent over $200 million more on beneficiaries with substance abuse
disorders than those without.
Presumably, in an effort to cut these costs, both the state and
national government have been supportive of the concept of making
detox an outpatient, rather than inpatient service.
Withdrawal from opioid drugs is generally not life threatening and can
be readily managed in less intensive and costly environments.
However, despite the support of more efficient, cost saving
alternatives, there is a shortage of community options for individuals
seeking assistance with opioid addiction. The lack of available
treatment facilities was raised several times at the recent
roundtables on the prescription drug abuse crisis held by the Senate
Standing Committee on Health and the Senate Standing Committee on
Alcoholism and Drug Abuse.
This demonstration program aims to address these issues by providing
alternative outpatient short term treatment, avoiding the unnecessary
emergency room costs, and studying the effectiveness of this
treatment model. The demonstration program established herein is
modeled after programs such as the Rose House Hospital Diversion
Program, located in Poughkeepsie, Voices of the Health, Inc., serving
Washington and Warren County, and the Essex County Crisis Alternatives
Program - which are all deemed to be successful programs providing
mental health respite services. While there will be costs to the
state associated with the creation of this demonstration, such costs
are expected to be offset by Medicaid savings resulting from the
decrease in emergency room services.
The costs of the program are expected to be offset by Medicaid savings.
view full text
S T A T E O F N E W Y O R K ________________________________________________________________________ 7326 I N S E N A T E May 2, 2012 ___________ Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to establishing an opioid addiction treatment and hospital diversion demonstration program THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 3309-b to read as follows: S 3309-B. OPIOID ADDICTION TREATMENT AND HOSPITAL DIVERSION DEMON- STRATION PROGRAM. 1. THE COMMISSIONER, IN CONSULTATION WITH THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES, SHALL, WITHIN THE AMOUNTS APPROPRIATED THEREFOR, ESTABLISH AN OPIOID ADDICTION TREATMENT AND HOSPITAL DIVERSION DEMONSTRATION PROGRAM. THIS PROGRAM SHALL PROVIDE A NEW MODEL OF DETOXIFICATION AND TRANSITIONAL SERVICES FOR INDIVIDUALS SEEKING TO RECOVER FROM OPIOID ADDICTION, THEREBY REDUCING RELIANCE ON EMERGENCY ROOM SERVICES. THE PROGRAM SHALL PROVIDE FOR THE TREATMENT OF PRESCRIPTION PAIN MEDICATION ADDICTION ON AN OUTPATIENT OR NON-MEDICAL RESIDENTIAL SHORT-TERM STAY BASIS. THE COMMISSIONER SHALL ESTABLISH UP TO SIX DEMONSTRATIONS THROUGHOUT THE STATE, AND AT MINIMUM A DEMON- STRATION SHALL BE ESTABLISHED IN EACH OF THE FOLLOWING AREAS: WESTERN NEW YORK, CENTRAL NEW YORK, STATEN ISLAND, BROOKLYN AND LONG ISLAND. 2. NOT LATER THAN TWO YEARS AFTER THE EFFECTIVE DATE OF THIS SECTION, THE COMMISSIONER SHALL PROVIDE THE GOVERNOR, THE TEMPORARY PRESIDENT OF THE SENATE, THE SPEAKER OF THE ASSEMBLY, THE CHAIR OF THE SENATE STAND- ING COMMITTEE ON HEALTH AND THE CHAIR OF THE ASSEMBLY HEALTH COMMITTEE WITH A WRITTEN EVALUATION OF THE DEMONSTRATION PROGRAM. SUCH EVALUATION SHALL ADDRESS THE OVERALL EFFECTIVENESS OF THIS TREATMENT MODEL AS IT RELATES TO PATIENTS, THE SURROUNDING COMMUNITY, HEALTH CARE PROVIDERS AND HEALTH CARE PAYORS, AND SHALL INCLUDE, BUT NOT BE LIMITED TO, THE EFFECTIVENESS OF THE PROGRAM IN PROVIDING ACCESS TO SERVICES, THE IMPACT OF THESE SERVICES, THE ASSOCIATED COSTS SAVINGS, AND WHETHER THE EXPAN- SION OF THIS OR SIMILAR MODELS ARE RECOMMENDED. S 2. This act shall take effect immediately. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD15691-01-2
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.